QT Vascular slightly narrows FY14 losses
QT Vascular said on Wednesday it has narrowed its net losses for the year ended Dec 31, 2014, to US$34.17 million, from US$34.52 million in the previous year.
Revenue more than doubled to US$13.2 million, mainly due to an increase in sales of its Chocolate PTA and Glider PTCA products with its distributors and direct coronary sales in the United States, it said.
Higher expenses - including higher business activities and professional service fees for its initial public offering and ongoing litigation, research and development expenses, and interest expenses relating to convertible notes - led the company into the red, however.
QT Vascular makes medical devices for the treatment of vascular diseases. The company was listed on the Catalist board last April.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Porsche posts Q1 profit drop on ramp-up costs
IBM plots US$730 million expansion of Canadian semiconductor site
Seatrium unit to fully redeem S$500 million worth of floating-rate bonds early
Yeo Guat Kwang, John Chen retiring from corporate boards
US: Wall St opens higher
Air China orders homegrown C919s in challenge to jet duopoly